256 related articles for article (PubMed ID: 14694118)
1. Potential selection of LMP1 variants in nasopharyngeal carcinoma.
Edwards RH; Sitki-Green D; Moore DT; Raab-Traub N
J Virol; 2004 Jan; 78(2):868-81. PubMed ID: 14694118
[TBL] [Abstract][Full Text] [Related]
2. Carboxy-terminal sequence variation of LMP1 gene in Epstein-Barr-virus-associated mononucleosis and tumors from Serbian patients.
Banko A; Lazarevic I; Cupic M; Stevanovic G; Boricic I; Jovanovic T
J Med Virol; 2012 Apr; 84(4):632-42. PubMed ID: 22337303
[TBL] [Abstract][Full Text] [Related]
3. Modified Anoikis Assay That Functionally Segregates Epstein-Barr Virus LMP1 Strains into Two Groups.
Wasil LR; Shair KHY
J Virol; 2018 Sep; 92(18):. PubMed ID: 29950426
[TBL] [Abstract][Full Text] [Related]
4. Epstein-barr virus latent membrane protein 1 polymorphism in nasopharyngeal carcinoma and other oral cavity tumors in Russia.
Senyuta N; Yakovleva L; Goncharova E; Scherback L; Diduk S; Smirnova K; Maksimovich D; Gurtsevitch V
J Med Virol; 2014 Feb; 86(2):290-300. PubMed ID: 24009107
[TBL] [Abstract][Full Text] [Related]
5. Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong.
Cheung ST; Leung SF; Lo KW; Chiu KW; Tam JS; Fok TF; Johnson PJ; Lee JC; Huang DP
Int J Cancer; 1998 May; 76(3):399-406. PubMed ID: 9579578
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1.
Nguyen-Van D; Ernberg I; Phan-Thi Phi P; Tran-Thi C; Hu L
Virus Genes; 2008 Oct; 37(2):273-81. PubMed ID: 18663567
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of latent membrane protein 1 in patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
Tabata YHibi S; Teramura T; Kuriyama K; Yagi T; Todo S; Sawada T; Imashuku S
Leuk Lymphoma; 2000 Jul; 38(3-4):373-80. PubMed ID: 10830744
[TBL] [Abstract][Full Text] [Related]
8. [Ancient variants of the Epstein-Barr virus (Herpesviridae, Lymphocryptovirus, HHV-4): hypotheses and facts.].
Smirnova KV; Senyuta NB; Lubenskaya AK; Dushenkina TE; Gurtsevich VE
Vopr Virusol; 2020; 65(2):77-86. PubMed ID: 32515563
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma.
Duraiswamy J; Sherritt M; Thomson S; Tellam J; Cooper L; Connolly G; Bharadwaj M; Khanna R
Blood; 2003 Apr; 101(8):3150-6. PubMed ID: 12468425
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia.
See HS; Yap YY; Yip WK; Seow HF
World J Surg Oncol; 2008 Feb; 6():18. PubMed ID: 18275617
[TBL] [Abstract][Full Text] [Related]
11. LMP1 strain variants: biological and molecular properties.
Mainou BA; Raab-Traub N
J Virol; 2006 Jul; 80(13):6458-68. PubMed ID: 16775333
[TBL] [Abstract][Full Text] [Related]
12. Amino acid changes in functional domains of latent membrane protein 1 of Epstein-Barr virus in nasopharyngeal carcinoma of southern China and Taiwan: prevalence of an HLA A2-restricted 'epitope-loss variant'.
Lin JC; Cherng JM; Lin HJ; Tsang CW; Liu YX; Lee SP
J Gen Virol; 2004 Jul; 85(Pt 7):2023-2034. PubMed ID: 15218188
[TBL] [Abstract][Full Text] [Related]
13. Genetic variations of EBV-LMP1 from nasopharyngeal carcinoma biopsies: potential loss of T cell epitopes.
Tang YL; Lu JH; Cao L; Wu MH; Peng SP; Zhou HD; Huang C; Yang YX; Zhou YH; Chen Q; Li XL; Zhou M; Li GY
Braz J Med Biol Res; 2008 Feb; 41(2):110-6. PubMed ID: 18297191
[TBL] [Abstract][Full Text] [Related]
14. Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas.
Jen KY; Higuchi M; Cheng J; Li J; Wu LY; Li YF; Lin HL; Chen Z; Gurtsevitch V; Fujii M; Saku T
Virus Genes; 2005 Mar; 30(2):223-35. PubMed ID: 15744579
[TBL] [Abstract][Full Text] [Related]
15. [Sequence analysis of the deletion and mutation in carboxy terminal region of the Epstein-Barr virus latent membrane protein 1 derived from nasopharyngeal carcinoma patients].
Tang MZ; Zheng YM; Guo XC; Zhang YL; Zeng Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):35-8. PubMed ID: 12870015
[TBL] [Abstract][Full Text] [Related]
16. [The LMP1 oncogene sequence variations in patients with oral tumours associated or not associated with the Epstein Barr].
Gurtsevitch VE; Iakovleva LS; Shcherbak LN; Goncharova EV; Smirnova KV; Diduk SV; Kondratova VN; Maksimovich DM; Lichtenstein AV; Seniuta NB
Mol Biol (Mosk); 2013; 47(6):987-95. PubMed ID: 25509860
[TBL] [Abstract][Full Text] [Related]
17. Lack of cytotoxic property in a variant of Epstein-Barr virus latent membrane protein-1 isolated from nasopharyngeal carcinoma.
Nitta T; Chiba A; Yamamoto N; Yamaoka S
Cell Signal; 2004 Sep; 16(9):1071-81. PubMed ID: 15212767
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the Variability of Epstein-Barr Virus Genes in Nasopharyngeal Biopsies: Potential Predictors for Carcinoma Progression.
Banko AV; Lazarevic IB; Folic MM; Djukic VB; Cirkovic AM; Karalic DZ; Cupic MD; Jovanovic TP
PLoS One; 2016; 11(4):e0153498. PubMed ID: 27071030
[TBL] [Abstract][Full Text] [Related]
19. [Study of sequence variations of Epstein-Barr virus LMP1 gene in nasopharyngeal carcinoma].
Lin SX; Zong YS; Zhang M; Han AJ; Zhong BL; Liang YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):791-5. PubMed ID: 16545188
[TBL] [Abstract][Full Text] [Related]
20. Selection pressure-driven evolution of the Epstein-Barr virus-encoded oncogene LMP1 in virus isolates from Southeast Asia.
Burrows JM; Bromham L; Woolfit M; Piganeau G; Tellam J; Connolly G; Webb N; Poulsen L; Cooper L; Burrows SR; Moss DJ; Haryana SM; Ng M; Nicholls JM; Khanna R
J Virol; 2004 Jul; 78(13):7131-7. PubMed ID: 15194789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
